US Officials Concede No Active Surveillance on Long-Term Effects of COVID-19 Vaccines

This article originally appeared on The Epoch Times and was republished with permission.

Guest post by Megan Redshaw

In a Feb. 15 hearing by the Select Subcommittee on the Coronavirus Pandemic, U.S. health officials side-stepped a question when asked whether the U.S. Food and Drug Administration (FDA) is actively conducting extended safety surveillance on those who received early COVID-19 vaccines.

🚨@US_FDA scientists warned their colleagues about the dangers of rushing COVID-19 vaccine approval.

The FDA ignored the warning, dismissed the scientists, and went forward with accelerated approval anyways.

Days later, the Biden Admin mandated the vaccine. pic.twitter.com/f2nU2kPGzj

— Select Subcommittee on the Coronavirus Pandemic (@COVIDSelect) February 15, 2024

Rep. Nicole Malliotakis (R-N.Y.) asked Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, whether the FDA is conducting active surveillance and if there are any specific health markers they’re studying that may signal trends requiring further inquiry.

“Every time we go through and do the safety surveillance, we start back, and it goes back to 2020. In some cases where we’re looking for certain things, we might use a different window, but indeed, we have to look from the beginning of the period of surveillance. I can turn it over to Dr. Jernigan because he can speak for CDC [Centers for Disease Control and Prevention] in that regard,” Dr. Marks said.

“So with regard to myocarditis, we certainly have been monitoring the issue with various different data systems. I think the most recent data really demonstrates that you’re about eight times less likely to get myocarditis if you’re vaccinated compared to those that are unvaccinated,” Dr. Daniel Jernigan, director of the National Center for Emerging and Zoonotic Infectious Diseases at the CDC responded.

FDA Director Dr. Peter Marks Says They Received an 'Avalanche' of Adverse Event Reports After the COVID-19 Vaccines Were Released

"We tried to be prepared for that but the avalanche of reports was tremendous."@RepBradWenstrup @COVIDSelect pic.twitter.com/RZNZRqjMBe

— Chief Nerd (@TheChiefNerd) February 15, 2024

Rep. Malliotakis told Jernigan she wanted to know about “everything,” not just myocarditis.

Dr. Jerrigan asked her to repeat the question, and she asked again whether the FDA was conducting extended safety surveillance on early recipients of COVID-19 vaccines.

“Most of the reports that we get of adverse events are in the few weeks following the vaccination,” Jernigan said. In terms of monitoring these over time, Jernigan said the agency has “vaccine effectiveness” systems in place at the CDC.

🚨BREAKING🚨

FDA Director Dr. Peter Marks admits "we probably have not done a good enough job" accurately informing Americans about confirmed COVID-19 vaccine deaths and injuries.
@RepDLesko demands an explanation👇 pic.twitter.com/rNvCVtsMxt

— Select Subcommittee on the Coronavirus Pandemic (@COVIDSelect) February 15, 2024

Neither Jernigan nor Marks referenced any active surveillance initiatives being undertaken by their agencies to monitor people who received the original COVID-19 vaccines for long-term health effects.

“There is no system in place for long-term vaccine safety surveillance in this country,” Ms. Liz Willner, founder of OpenVAERS, told The Epoch Times.

🚨🚨🚨

Biden Administration @HRSAgov Director admits the COVID-19 vaccine was mandated without a sufficient system in place to compensate the Americans injured by the coercive policies.
@RepMMM uncovers the truth👇 pic.twitter.com/apyxVGY0y7

— Select Subcommittee on the Coronavirus Pandemic (@COVIDSelect) February 15, 2024

“The FDA and CDC do not actively search for safety signals. They did not find the myocarditis or the thrombosis with thrombocytopenia syndrome that led to the withdrawal of the J&J COVID vaccine—those signals were discovered by the European Medicines Agency. The Vaccine Safety Datalink has never corroborated any vaccine safety signals, including myocarditis, because you cannot find what you are not looking for,” she added.

Congresswoman Greene (R-GA) highlights the hundreds of thousands VAERS reports, but says the government has only approved ELEVEN claims for v-injury compensation.

She notes the average payout was only $3K—despite some having to pay hundreds of thousands ANNUALLY for treatment. pic.twitter.com/S9yOrN3T2u

— Te𝕏asLindsay™ (@TexasLindsay_) February 15, 2024

Read the full story at The Epoch Times.